Erratum

Global trends and scientific networks in mesenchymal stem cell research in hematology: a 20-year bibliometric insight

Volume: 6 Number: 5 October 24, 2025
EN TR

Global trends and scientific networks in mesenchymal stem cell research in hematology: a 20-year bibliometric insight

The original article was published on August 31, 2025. https://dergipark.org.tr/en/pub/jompac/article/1701122

Erratum Note

In the original article, the ORCID of one of the co-authors, Edanur Dilara Mandacı, was incorrectly reported by the corresponding author. At the request of the authors, the ORCID has been corrected to reflect the accurate information. This correction does not affect the content or conclusions of the article. The authors apologize for this oversight.

Abstract

Aims: Mesenchymal stem cells (MSCs) are multipotent stromal cells that are differentiated due to their differentiation potential and immunomodulatory activities, which is highly relevant to regenerative medicine and hematological therapies. MSCs remain one of the most actively pursued research areas in bioengineering, however, their bibliometric structure in the context of hematology is MSCs has not been thoroughly investigated. In this particular case, we set out to assess MSCs in the field of hematology by evaluating scientific output, its thematic evolution, as well as patterns of global collaboration using bibliometric techniques. Methods: With the keyword “MSCs” in the title and restricted to the “hematology” category, a total of 1.656 publications from the years 2005 to 2024 were retrieved using Web of Science Core Collection. The data was analyzed using VOSviewer (v1.6.11) and SPSS (v25.0). Trends in annual publication activities, journal output per publication, citation rates of the most cited works, co authored keyword networks, institutional and author cooperation networks, and and citation activity by country was examined. Results: As noted, there was a significant increase in the publication rate from 2011-2015, followed by a decrease after this period. Over 65% of publications were contributed by two journals–Stem Cells and Development and Stem Cells. Studies that received the most citations concentrated on the immunomodulatory mechanisms of MSCs and the specific properties of tissues. University of Genoa claimed the highest citation count per article, whereas Chinese higher education institutions published the most on the topic. Core themes such as ‘differentiation,’ ‘bone marrow,’ ‘transplantation,’ and ‘exosomes’ emerged from the analysis on keyword clustering. The most noteworthy research backbone on the topic was developed collaboratively between the US and China, who both possessed strong global network intercontinental links. Conclusion: Research on MSCs in the context of hematology showcases mature thematic development, intensive institutional collaboration, and regional collaboration clustering. The area of MSCs in hematology indicates foundational research exhaustion, but an expanding focus on exosomes and therapies that do not involve cells signals prospective, shift aimed at clinical. The work can strategically direct funding, policy, and interdisciplinary collaboration MSCs in policymaking guidance MSCs in hematology applications mean interdisciplinary MSCs guide policy.

Keywords

Supporting Institution

This research received no financial support from any funding agency, commercial or not-for-profit sectors.

Ethical Statement

This study is based on bibliometric analysis and therefore does not require approval from an ethics committee

Thanks

The author(s) declare that there is no acknowledgment to disclose.

References

  1. Ding DC, Shyu WC, Lin SZ. Mesenchymal stem cells. Cell Transplant. 2011;20(1):5-14. doi:10.3727/096368910X
  2. Bianco P. “Mesenchymal” stem cells. Annu Rev Cell Dev Biol. 2014;30(1): 677-704. doi:10.1146/annurev-cellbio-100913-013132
  3. Caplan AI. Mesenchymal stem cells: time to change the name! Stem Cells Transl Med. 2017;6(6):1445-1451. doi:10.1002/sctm.17-0051
  4. Saadh MJ, Hussein A, Bayani A, et al. Mesenchymal stem cell-derived exosomes: a novel therapeutic frontier in hematological disorders. Med Oncol. 2025;42(6):1-16. doi:10.1007/s12032-025-02742-0
  5. Nachmias B, Zimran E, Avni B. Mesenchymal stroma/stem cells: haematologists’ friend or foe? Br J Haematol. 2022;199(2):175-189. doi: 10.1111/bjh.18292
  6. Hezam K, Fu E, Zhang J, Li Z. Therapeutic trends of priming mesenchymal stem cells: a bibliometric analysis. Biochem Biophys Rep. 2024;38:101708. doi:10.1016/j.bbrep.2024.101708
  7. Nurbaeva MK, Dzhunushalieva G. Bibliometric analysis of literature on stem cells in regenerative medicine and their clinical applications (2010 to 2024). Precis Future Med. 2024;8(4):137-155. doi:10.23838/pfm.2024. 00121
  8. Li LL, Ding G, Feng N, Wang MH, Ho YS. Global stem cell research trend: bibliometric analysis as a tool for mapping of trends from 1991 to 2006. Scientometrics. 2009;80(1):39-58. doi:10.1007/s11192-008-1939-5

Details

Primary Language

English

Subjects

Haematology

Journal Section

Erratum

Publication Date

October 24, 2025

Submission Date

May 16, 2025

Acceptance Date

June 20, 2025

Published in Issue

Year 2025 Volume: 6 Number: 5

APA
Mandacı Şanlı, N., & Mandacı, E. D. (2025). Global trends and scientific networks in mesenchymal stem cell research in hematology: a 20-year bibliometric insight. Journal of Medicine and Palliative Care, 6(5), 614-614. https://doi.org/10.47582/jompac.1809945
AMA
1.Mandacı Şanlı N, Mandacı ED. Global trends and scientific networks in mesenchymal stem cell research in hematology: a 20-year bibliometric insight. J Med Palliat Care / JOMPAC / jompac. 2025;6(5):614-614. doi:10.47582/jompac.1809945
Chicago
Mandacı Şanlı, Neslihan, and Edanur Dilara Mandacı. 2025. “Global Trends and Scientific Networks in Mesenchymal Stem Cell Research in Hematology: A 20-Year Bibliometric Insight”. Journal of Medicine and Palliative Care 6 (5): 614-14. https://doi.org/10.47582/jompac.1809945.
EndNote
Mandacı Şanlı N, Mandacı ED (October 1, 2025) Global trends and scientific networks in mesenchymal stem cell research in hematology: a 20-year bibliometric insight. Journal of Medicine and Palliative Care 6 5 614–614.
IEEE
[1]N. Mandacı Şanlı and E. D. Mandacı, “Global trends and scientific networks in mesenchymal stem cell research in hematology: a 20-year bibliometric insight”, J Med Palliat Care / JOMPAC / jompac, vol. 6, no. 5, pp. 614–614, Oct. 2025, doi: 10.47582/jompac.1809945.
ISNAD
Mandacı Şanlı, Neslihan - Mandacı, Edanur Dilara. “Global Trends and Scientific Networks in Mesenchymal Stem Cell Research in Hematology: A 20-Year Bibliometric Insight”. Journal of Medicine and Palliative Care 6/5 (October 1, 2025): 614-614. https://doi.org/10.47582/jompac.1809945.
JAMA
1.Mandacı Şanlı N, Mandacı ED. Global trends and scientific networks in mesenchymal stem cell research in hematology: a 20-year bibliometric insight. J Med Palliat Care / JOMPAC / jompac. 2025;6:614–614.
MLA
Mandacı Şanlı, Neslihan, and Edanur Dilara Mandacı. “Global Trends and Scientific Networks in Mesenchymal Stem Cell Research in Hematology: A 20-Year Bibliometric Insight”. Journal of Medicine and Palliative Care, vol. 6, no. 5, Oct. 2025, pp. 614-, doi:10.47582/jompac.1809945.
Vancouver
1.Neslihan Mandacı Şanlı, Edanur Dilara Mandacı. Global trends and scientific networks in mesenchymal stem cell research in hematology: a 20-year bibliometric insight. J Med Palliat Care / JOMPAC / jompac. 2025 Oct. 1;6(5):614-. doi:10.47582/jompac.1809945

TR DİZİN ULAKBİM and International Indexes (1d)

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS]
 


 

download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiVHJfSW5kZXhfbG9nby5wbmciLCJwYXRoIjoiN2EzMC84NTVhL2UyMWMvNjlkZjRkZmVhNTUyNTYuNzg3NjU2ODgucG5nIiwiZXhwIjoxNzc2MjQ1Nzc0LCJub25jZSI6IjU0MDZkMWE2NmE1Y2QwZTJjNGYyNDA1OTM2MTE0YWIxIn0.Tt-WScFXTj5r2jji5eDMFApNzujLMjMPl8ivXRbozSI



f9ab67f.png
asos-index.png


 


download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiQ3Jvc3NyZWYuanBnIiwicGF0aCI6IjAzMzEvMTdkZi8yN2ZkLzY5ZGY0ZThhMDZkMjg0LjQxMjAyNDg5LmpwZyIsImV4cCI6MTc3NjI0NTkxNCwibm9uY2UiOiI2NjM1Yjc5MWFiY2I1MDQ0NjkzMTAxMDhjY2Y2NzRlMCJ9.5jDQBEY-KErkDK1QjDmv9ichOkNIn5CWYibe1Wz1644
icmje_1_orig.png
 
cc.logo.large.png
 
ncbi.png
 
google-scholar.pngpn6krf5.jpg
 


 

Our journal is in TR-Dizin, DRJI (Directory of Research Journals Indexing, General Impact Factor, Google Scholar, Researchgate, CrossRef (DOI), ROAD, ASOS Index, Turk Medline Index, Eurasian Scientific Journal Index (ESJI), and Turkiye Citation Index.

EBSCO, DOAJ, OAJI and ProQuest Index are in process of evaluation. 

 

Journal articles are evaluated as "Double-Blind Peer Review"